Shaman Secondary Stock Offering May Preserve Nasdaq Listing
Executive Summary
A stock offering of convertible, royalty-bearing shares by Shaman Pharmaceuticals may allow the biotech company to avoid de-listing proceedings by the Nasdaq stock market.